Registry and Tissue Banking Study of Cancer, Blood Disorder and Immunodeficiency Patients

Long-term Follow-up Registry and Biorepository for Patients Diagnosed With Primary Immunodeficiencies, Malignancy, and/or Eligible to Undergo Hematopoietic Stem Cell Transplant

Protocol Description

Through this protocol, researchers will collect clinical information, blood, urine, and tissue from patients receiving treatment for a blood cancer or solid tumor cancer, a primary immunodeficiency or a condition being treated with stem cell transplant. Tissue banking studies such as this one help researchers better understand medical conditions and how different people respond to disease therapies.

Eligibility Criteria

Subject to certain exclusion criteria, this study is enrolling participants of both genders, through age 79 who have a blood cancer or solid tumor cancer, a primary immunodeficiency or a condition being treated with stem cell transplant.
Males and Females: Through age 79

Requirements

With consent, medical record information of participants will be entered into the study database. Blood samples, bone marrow samples and urine will be collected for the database when these biologic samples are collected as part of normal care for the various studied conditions.
Visits: None beyond normal clinical care for the condition
Duration: Individual’s medical record information will be updated as long as participants remain in study.

Status: Open to Enrollment

Primary Investigator

Craig Byersdorfer, MD, PhD

Contact Information

For more information about the study or enrollment, please contact:
Shawna McIntyre, Clinical Research Supervisor
412-692-6740